Form D — Noveome Biotherapeutics, Inc.
0001478304-26-000003 · filed Aug 27, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $15,000,000
- Total sold
- $6,750,503
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Noveome Biotherapeutics, Inc.
- CIK
- 1478304
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 620 ALPHA DRIVE
PITTSBURGH, PA 15238 - Phone
- 412-799-6157
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Patrick Welch · Executive OfficerPittsburgh, PA Find on LinkedIn ↗
-
Robert Langer · DirectorPittsburgh, PA Find on LinkedIn ↗
-
Ronald Poropatich · DirectorPittsburgh, PA Find on LinkedIn ↗
-
Eric Keller · Executive OfficerPittsburgh, PA Find on LinkedIn ↗
-
Houman Hemmati · DirectorPittsburgh, PA Find on LinkedIn ↗
-
Craig Nemiroff · DirectorPittsburgh, PA Find on LinkedIn ↗
-
Michael Kaufman · DirectorPittsburgh, PA Find on LinkedIn ↗
-
Karin Potoka · Executive OfficerPittsburgh, PA Find on LinkedIn ↗
-
Larry Brown · Executive OfficerPittsburgh, PA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗